miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients

Ovarian cancer (OC) remains a leading cause of gynecological cancer‐related death worldwide, characterized by poor 5‐year survival. Molecular markers could serve as crucial tools of personalized prognosis and therapy. Herein, we present miR‐181a as novel predictor of OC prognosis, using five indepen...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:International Journal of Cancer Ročník 147; číslo 12; s. 3560 - 3573
Hlavní autori: Panoutsopoulou, Konstantina, Avgeris, Margaritis, Magkou, Paraskevi, Mavridis, Konstantinos, Dreyer, Tobias, Dorn, Julia, Obermayr, Eva, Reinthaller, Alexander, Michaelidou, Kleita, Mahner, Sven, Vergote, Ignace, Loverix, Liselore, Braicu, Ioana, Sehouli, Jalid, Zeillinger, Robert, Magdolen, Viktor, Scorilas, Andreas
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Hoboken, USA Wiley 15.12.2020
John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Predmet:
ISSN:0020-7136, 1097-0215, 1097-0215
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Buďte prvý, kto okomentuje tento záznam!
Najprv sa musíte prihlásiť.